In contrast, there was no significant decrease in the serum GSH/GSSG ratio or increase in carbonyl content of serum proteins
Both oxidative damage to cells and a decrease in antioxidant ability contribute to this disease
Total weight loss at 48-68 weeks on the combination is difficult to predict without clinical trial data, but based on individual compound data (retatrutide at 24-28.7% and the additive benefit seen with CagriSema), a reasonable estimate for the combination is 25-35% total body weight reduction in high responders
Ki67 is present during all active phases of the cell cycle (G1, S, G2, and M) but absent in resting cells (G0), making it a key marker for assessing tumor cell proliferation
the four components stay in their fixed manufacturing ratio
UV exposure is the leading driver of premature skin aging, so sun protection helps preserve the gains from any topical therapy